DrugPatentWatch - Biopharmaceutical Business Intelligence
Profile for Akebia Therapeutics, Inc. (AKBA)
« Back to company indexAKBA Chatter Timeline
Stock Ticker for AKBA
Most Active Tweeters for AKBA
No tweets foundRecent Tweets for AKBA
 |
@beyond_ninety Bkd Wealth Advisors Raised Its Lakeland Finl $LKFN Stake; Perceptive Advisors Upped Akebia Therapeutics $AKBA Holdi… https://t.co/TWxJMDo0Te August 20th 2018, 7:08am |
 |
@OlympiaReport Akebia Therapeutics Inc $AKBA Receives $21.50 Consensus PT from Brokerages https://t.co/Cr6euV5BNh August 19th 2018, 4:08pm |
 |
@MareaInformativ Akebia Therapeutics Inc $AKBA Receives Consensus Rating of “Buy” from Brokerages https://t.co/22L8ZzFk13 August 19th 2018, 4:08pm |
 |
@TranscriptDaily Akebia Therapeutics $AKBA Raised to Buy at Zacks Investment Research https://t.co/NrzkJSOdwL August 19th 2018, 5:08am |
 |
@1MinuteStock Wondering about risks of $AKBA? The 21-day volatility is 17.87% https://t.co/PGIz4jyyqQ August 19th 2018, 5:08am |
|
@1MinuteStock We calculated 21-day Expected Return of $AKBA for you: -24.1% https://t.co/3YF6WoRJbF August 19th 2018, 4:08am |
|
@OlympiaReport Akebia Therapeutics $AKBA Upgraded by Zacks Investment Research to Buy https://t.co/zYcei5imWm August 18th 2018, 2:08pm |
 |
@dispatchtribune Akebia Therapeutics $AKBA Raised to Buy at Zacks Investment Research https://t.co/POzFp4rBdZ August 18th 2018, 2:08pm |
|
@MareaInformativ Akebia Therapeutics $AKBA Price Target Cut to $18.00 by Analysts at Needham & Company LLC https://t.co/aOR3XqksSi August 17th 2018, 9:08am |
 |
@bbnsnews Akebia Therapeutics $AKBA Upgraded to Buy by Zacks Investment Research https://t.co/jMAMQOqMZO August 17th 2018, 8:08am |
|
@bbnsnews Akebia Therapeutics $AKBA Now Covered by Analysts at Raymond James https://t.co/4tyhPXRrJx August 17th 2018, 6:08am |
 |
@a3igner TradeFlags : TD BUY $AKBA at 7.88, Supp 7.59 Resis 10.49 R38 HiLo 4% T1Y 21 buy 2.0 fwdPE -4.3 DIV N/A #Akebia The… https://t.co/GiwqUyp7IL August 16th 2018, 11:08pm |
 |
@TradeFlags TD BUY $AKBA at 7.88, Supp 7.59 Resis 10.49 R38 HiLo 4% T1Y 21 buy 2.0 fwdPE -4.3 DIV N/A #Akebia The #stocks… https://t.co/S1FqIR8lY7 August 16th 2018, 11:08pm |
|
@TranscriptDaily -$0.77 EPS Expected for Akebia Therapeutics Inc $AKBA This Quarter https://t.co/j4WhqEqQaT August 16th 2018, 5:08pm |
|
@dispatchtribune Akebia Therapeutics Inc $AKBA Expected to Announce Quarterly Sales of $39.71 Million https://t.co/skaoLcwKPz August 16th 2018, 5:08pm |
 |
@registrarjourn Zacks: Brokerages Expect Akebia Therapeutics Inc $AKBA Will Announce Quarterly Sales of $39.71 Million https://t.co/lk1dnU92Q4 August 16th 2018, 5:08pm |
 |
@EnterpriseLeade Zacks: Brokerages Expect Akebia Therapeutics Inc $AKBA Will Announce Quarterly Sales of $39.71 Million https://t.co/pW0kxOW2k4 August 16th 2018, 5:08pm |
 |
@ZolmaxNews Akebia Therapeutics $AKBA Upgraded to Buy by Zacks Investment Research https://t.co/1lV1VNjep9 August 16th 2018, 12:08pm |
|
@MareaInformativ Akebia Therapeutics $AKBA Upgraded to Buy by Zacks Investment Research https://t.co/w54mZ16PDV August 16th 2018, 12:08pm |
 |
@NextGenStock $AKBA added. Focuses on dev and comm of novel therapies for patients with renal disease through hypoxia-inducible f… https://t.co/hz1AKT1VmQ August 16th 2018, 8:08am |
 |
@dakotafinancial Akebia Therapeutics $AKBA Earns Buy Rating from Analysts at Raymond James https://t.co/JHfBLgWDVN August 16th 2018, 4:08am |
 |
@WeekHerald Zacks Investment Research Upgrades Akebia Therapeutics $AKBA to Buy https://t.co/RTtsvBlkiB August 15th 2018, 5:08pm |
 |
@ThisLincolnian Zacks Investment Research Upgrades Akebia Therapeutics $AKBA to Buy https://t.co/dB9MeSynKu August 15th 2018, 5:08pm |
|
@beyond_ninety Nantahala Capital Management Has Upped Akebia Therapeutics $AKBA Holding; Two Harbors Investment Has 0.25 Sentiment https://t.co/l7KhgSNuk1 August 15th 2018, 3:08pm |
|
@bbnsnews Q3 2018 Earnings Forecast for Akebia Therapeutics Inc Issued By Piper Jaffray Companies $AKBA https://t.co/pWcDNov44S August 15th 2018, 8:08am |
|
@beyond_ninety Roundview Capital Lowered Its Holding in Ross Stores $ROST as Stock Declined; Akebia Therapeutics $AKBA Market Valu… https://t.co/Vq4f4pIraT August 15th 2018, 5:08am |
 |
@TickerReport Akebia Therapeutics $AKBA Now Covered by Raymond James https://t.co/t1TTYy1qth August 15th 2018, 5:08am |
 |
@dailypoliticaln Akebia Therapeutics $AKBA Now Covered by Raymond James https://t.co/Vk7qRBSfwh August 15th 2018, 5:08am |
|
@dakotafinancial Akebia Therapeutics $AKBA Hits New 52-Week Low Following Analyst Downgrade https://t.co/Xn5XU7dSt2 August 15th 2018, 1:08am |
 |
@bibeypost_stock Will New Ratings Coverage by Raymond James Help Akebia Therapeutics $AKBA Stock This Week? - https://t.co/7esPwiZ3Bm August 14th 2018, 6:08pm |
 |
@reurope_stock Akebia Therapeutics $AKBA Hit With Outperform Rating From Raymond James, Analysts Expect $18 Stock Price https://t.co/1XqDwHHu1X August 14th 2018, 6:08pm |
 |
@The_CasualSmart It is Time to "Outperform" Akebia Therapeutics $AKBA, Raymond James Says. Stock May Be Worth $18 https://t.co/J862uCYikU August 14th 2018, 6:08pm |
 |
@mmahotstuff1 Raymond James Says Its Time To Outperform Akebia Therapeutics $AKBA. Will Stock Hit Their Target of $18? - https://t.co/5LKgsiZaEa August 14th 2018, 6:08pm |
 |
@whatsonthorold2 Akebia Therapeutics $AKBA Moves On Raymond James Initiation. How Much Are Shares Worth? - https://t.co/BbnSCOeYWj August 14th 2018, 6:08pm |
 |
@west_moreland Will New Ratings Coverage by Raymond James Help Akebia Therapeutics $AKBA Stock This Week? https://t.co/tfVYjfEfNO August 14th 2018, 6:08pm |
|
@The_CasualSmart Will New Ratings Coverage by Raymond James Help Akebia Therapeutics $AKBA Stock This Week? https://t.co/sXMoaIw7GF August 14th 2018, 6:08pm |
 |
@Fanob_stock Akebia Therapeutics $AKBA Hit With Outperform Rating From Raymond James, Analysts Expect $18 Stock Price https://t.co/omB29ByWGv August 14th 2018, 6:08pm |
|
@WeekHerald Akebia Therapeutics Inc $AKBA Expected to Post Earnings of -$0.64 Per Share https://t.co/nowwkMtNoO August 14th 2018, 1:08pm |
|
@TranscriptDaily Akebia Therapeutics Inc $AKBA Given Average Rating of “Buy” by Analysts https://t.co/viDs7m1sLU August 14th 2018, 1:08pm |
 |
@AmericanBanking Akebia Therapeutics Inc $AKBA Given Average Rating of “Buy” by Analysts https://t.co/XVblFSWNix #stocks August 14th 2018, 1:08pm |
|
@ThisLincolnian Analysts Anticipate Akebia Therapeutics Inc $AKBA Will Post Earnings of -$0.64 Per Share https://t.co/7s4EbWivfx August 14th 2018, 1:08pm |
 |
@TheMarketsDaily Akebia Therapeutics $AKBA Coverage Initiated at Raymond James https://t.co/gbgkTOzBFi August 14th 2018, 1:08pm |
 |
@AlertTrade SOCIAL ACTIVITY: $AKBA - AKEBIA THERAPEUTICS ? TradeIdeas via ? https://t.co/VS8RO1bzXJ August 14th 2018, 9:08am |
 |
@BioStocks $AKBA initiated at Outperform at Raymond James August 14th 2018, 6:08am |
|
@WeekHerald Needham & Company LLC Lowers Akebia Therapeutics $AKBA Price Target to $18.00 https://t.co/bQZIEdKyEE August 14th 2018, 5:08am |
|
@ThisLincolnian Needham & Company LLC Lowers Akebia Therapeutics $AKBA Price Target to $18.00 https://t.co/KsnoWJKqy6 August 14th 2018, 5:08am |
|
@The_CasualSmart Bremer Trust National Association Trimmed Ipg Photonics $IPGP Stake; Akebia Therapeutics $AKBA SI Decreased By 0.36% https://t.co/1iVNm8DK6w August 14th 2018, 5:08am |
 |
@ConsumerFeed Akebia Therapeutics Inc Expected to Post Q3 2018 Earnings of -$0.67 Per Share $AKBA https://t.co/Hq5jUoj0nU August 14th 2018, 4:08am |
|
@WeekHerald Akebia Therapeutics $AKBA Reaches New 1-Year Low Following Analyst Downgrade https://t.co/5PivKLJQzb August 14th 2018, 1:08am |
|
@ThisLincolnian Akebia Therapeutics $AKBA Reaches New 12-Month Low Following Analyst Downgrade https://t.co/MRTMUMltd0 August 14th 2018, 1:08am |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2018. All rights reserved.